While a correlation between tumour burden and serum CA125 levels was found in vehicle-treated mice, carboplatin-treated animals had undetectable levels of human serum CA125 immediately post therapy despite presence of residual tumour (Fig. 7d, Supplementary Data 1, Supplementary Fig 10c and Supplementary Data 2). The gene discussed is MUC16; the disease is neoplasm.